The effect of storage on the behaviour of Eudragit NE free film

Journal of Thermal Analysis and Calorimetry

Volumn 73, Issue 2, 2003, Pages 607-613

  Bajdik, J ^a   Pintye Hodi K ^a   Regdon Jr , G ^a   Fazekas, P ^b   Szabo Revesz P ^a   Eros I ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Crystallisation; Eudragit NE 30 D; Film thickness; Nonoxynol 100; Storage

Indexed keywords

ATMOSPHERIC HUMIDITY; COATINGS; CRYSTALLIZATION; MECHANICAL PERMEABILITY; TENSILE STRENGTH; COPOLYMERS; DATA REDUCTION; DISSOLUTION; DRUG PRODUCTS; EMULSIFICATION; HEAT TRANSFER; PARAMETER ESTIMATION; PLASTIC COATINGS; POLYTETRAFLUOROETHYLENES; STORAGE (MATERIALS); STRETCHING; TENSILE TESTING; THICKNESS MEASUREMENT;

FILM THICKNESS; SOLID SURFACES; STORAGE CONDITIONS;

DRUG PRODUCTS; FILM PREPARATION;

EID: 0042382897     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025438415304     Document Type: Conference Paper

References (23)

1. J. Bajdik, K. Pintye-Hódi, Cs. Novák, P. Szabó-Révész, G. Regdon Jr., I. Erös and G. Pokol, J. Therm. Anal. Cal., 63 (2000) 798.
2. J. Bajdik, K. Pintye-Hódi, Cs. Novák, A. Kelemen, G. Regdon Jr. and I. Erös, J. Therm. Anal. Cal., 68 (2002) 613.
3. G. Cole, Pharmaceutical coating technology, Taylor & Francis Ltd., London, UK 1995, p. 27.
4. K. Lehmann, Practical Course in Film Coating of Pharmaceutical Dosage Forms with Eudragit®, Pharma Polymers, Darmstadt, Germany 1999, p. 8.
5. L. Genç, H. Bilaç and E. Güler, Pharm. Acta Helv., 74 (1999) 43.
6. C. F. Wong, K. H. Yuen and K. K. Peh, Int. J. Pharm., 178 (1999) 11.
7. W. Sawicki, Eur. J. Pharm. Biopharm., 53 (2002) 29.
8. S. Lieb, R. M. Szeimies and G. Lee, Eur. J. Pharm. Biopharm., 53 (2002) 99.
9. R. Semdé, K. Amighi, M. J. Devleeschouwer and A. J. Moës, Int. J. Pharm., 197 (2000) 181.
10. H. U. Petereit and W. Weisbrod, Eur. J. Pharm. Biopharm., 47 (1999) 15.
11. J. C. Gutierrez-Rocca and J. W. McGinity, Drug Dev. Ind. Pharm., 19 (1993) 315.
12. K. Amighi and A. J. Moes, S. T. P. Pharma Sciences, 7 (1997) 141.
13. R. Hyppölä, I. Husson and F. Sundholm, Int. J. Pharm., 133 (1996) 161.
14. K. Johnson, R. Hathaway, P. Leung and R. Franz, Int. J. Pharm., 73 (1991) 197.
15. C. Wu and J. W. McGinity, Int. J. Pharm., 177 (1999) 15.
16. K. Lehmann, H. U. Petereit and D. Dreher, Pharm. Ind., 55 (1993) 940.
17. J. T. Heinämäki, S. S. Ojantakanen, L. M. Hellén and J. K. Yliruusi, Pharm. Ind., 57 (1995) 68.
18. N. Sarisuta and K. Punpreuk, J. Cont. Rel., 31 (1994) 215.
19. A. Y. Lin, N. A. Muhammad, D. Pope and L. L. Augsburger, AAPS PharmSci, 3 (2002) article 14.
20. R. Zelkó, Á. Orbán, J. Nagy, G. Csóka and I. Rácz, J. Therm. Anal. Cal., 68 (2002) 531.
21. A. R. Bilia, M. C. Bergonzi, F. Morgenni, G. Mazzi and F. F. Vincieri, Int. J. Pharm., 213 (2001) 199.
22. M. E. Gil-Alegre, J. A. Bernabeu, M. A. Camacho and A. I. Torres-Suarez, II Farmaco, 56 (2001) 877.
23. K. H. Bauer, K. Lehmann, H. P. Osterwald and G. Rothgang, Überzogene Arzneiformen, Wissenscaftliche Verlagsgesselschaft mbH, Stuttgart, Germany 1988, p. 100.